Matches in Wikidata for { <http://www.wikidata.org/entity/Q90642530> ?p ?o ?g. }
- Q90642530 description "2020 nî lūn-bûn" @default.
- Q90642530 description "2020年の論文" @default.
- Q90642530 description "2020年学术文章" @default.
- Q90642530 description "2020年学术文章" @default.
- Q90642530 description "2020年学术文章" @default.
- Q90642530 description "2020年学术文章" @default.
- Q90642530 description "2020年学术文章" @default.
- Q90642530 description "2020年学术文章" @default.
- Q90642530 description "2020年學術文章" @default.
- Q90642530 description "2020年學術文章" @default.
- Q90642530 description "2020年學術文章" @default.
- Q90642530 description "2020年學術文章" @default.
- Q90642530 description "2020年學術文章" @default.
- Q90642530 description "2020년 논문" @default.
- Q90642530 description "article científic" @default.
- Q90642530 description "article scientific" @default.
- Q90642530 description "article scientifique" @default.
- Q90642530 description "articol științific" @default.
- Q90642530 description "articolo scientifico" @default.
- Q90642530 description "artigo científico" @default.
- Q90642530 description "artigo científico" @default.
- Q90642530 description "artigo científico" @default.
- Q90642530 description "artikel ilmiah" @default.
- Q90642530 description "artikull shkencor" @default.
- Q90642530 description "artikulong pang-agham" @default.
- Q90642530 description "artykuł naukowy" @default.
- Q90642530 description "artículo científico publicado en 2020" @default.
- Q90642530 description "artículu científicu" @default.
- Q90642530 description "bilimsel makale" @default.
- Q90642530 description "bài báo khoa học" @default.
- Q90642530 description "naučni članak" @default.
- Q90642530 description "scienca artikolo" @default.
- Q90642530 description "scientific article published on 06 March 2020" @default.
- Q90642530 description "scientific article published on 6 March 2020" @default.
- Q90642530 description "scientific article published on 6 March 2020" @default.
- Q90642530 description "teaduslik artikkel" @default.
- Q90642530 description "tieteellinen artikkeli" @default.
- Q90642530 description "tudományos cikk" @default.
- Q90642530 description "vedecký článok" @default.
- Q90642530 description "vetenskaplig artikel" @default.
- Q90642530 description "videnskabelig artikel udgivet 6. marts 2020" @default.
- Q90642530 description "vitenskapelig artikkel" @default.
- Q90642530 description "vitskapeleg artikkel" @default.
- Q90642530 description "vědecký článek" @default.
- Q90642530 description "wetenschappelijk artikel" @default.
- Q90642530 description "wissenschaftlicher Artikel" @default.
- Q90642530 description "επιστημονικό άρθρο" @default.
- Q90642530 description "мақолаи илмӣ" @default.
- Q90642530 description "наукова стаття, опублікована в березні 2020" @default.
- Q90642530 description "научна статия" @default.
- Q90642530 description "научная статья" @default.
- Q90642530 description "научни чланак" @default.
- Q90642530 description "научни чланак" @default.
- Q90642530 description "מאמר מדעי" @default.
- Q90642530 description "مقالة علمية نشرت في 6 مارس 2020" @default.
- Q90642530 description "৬ মার্চ ২০২০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q90642530 description "บทความทางวิทยาศาสตร์" @default.
- Q90642530 description "სამეცნიერო სტატია" @default.
- Q90642530 name "Clinical and Immunological Outcomes in High-Risk Resected Melanoma Patients Receiving Peptide-Based Vaccination and Interferon Alpha, With or Without Dacarbazine Preconditioning: A Phase II Study" @default.
- Q90642530 name "Clinical and Immunological Outcomes in High-Risk Resected Melanoma Patients Receiving Peptide-Based Vaccination and Interferon Alpha, With or Without Dacarbazine Preconditioning: A Phase II Study" @default.
- Q90642530 type Item @default.
- Q90642530 label "Clinical and Immunological Outcomes in High-Risk Resected Melanoma Patients Receiving Peptide-Based Vaccination and Interferon Alpha, With or Without Dacarbazine Preconditioning: A Phase II Study" @default.
- Q90642530 label "Clinical and Immunological Outcomes in High-Risk Resected Melanoma Patients Receiving Peptide-Based Vaccination and Interferon Alpha, With or Without Dacarbazine Preconditioning: A Phase II Study" @default.
- Q90642530 prefLabel "Clinical and Immunological Outcomes in High-Risk Resected Melanoma Patients Receiving Peptide-Based Vaccination and Interferon Alpha, With or Without Dacarbazine Preconditioning: A Phase II Study" @default.
- Q90642530 prefLabel "Clinical and Immunological Outcomes in High-Risk Resected Melanoma Patients Receiving Peptide-Based Vaccination and Interferon Alpha, With or Without Dacarbazine Preconditioning: A Phase II Study" @default.
- Q90642530 P1433 Q90642530-3D299254-7A62-49AF-8406-3C02A46682AC @default.
- Q90642530 P1476 Q90642530-DEC4D6CF-F8D3-4892-9A32-AA03BB7149AB @default.
- Q90642530 P2093 Q90642530-0A803BDF-D6D7-4C46-8031-CBAB58D5223C @default.
- Q90642530 P2093 Q90642530-0E1192E8-FA7C-41C4-852D-37C8FBE9366A @default.
- Q90642530 P2093 Q90642530-0E31E35B-A6A7-407A-9006-7DF90E4ADB88 @default.
- Q90642530 P2093 Q90642530-11D3F4F1-94BB-4D15-966C-6776833225CE @default.
- Q90642530 P2093 Q90642530-36E53AF3-E2AF-4170-BDB2-D2B96B45F7F5 @default.
- Q90642530 P2093 Q90642530-3FE6ECBC-AAB2-4DC2-8571-19EBEC025E0F @default.
- Q90642530 P2093 Q90642530-41B90277-E114-4C97-AAA4-A2065B5B3293 @default.
- Q90642530 P2093 Q90642530-4DB372C4-941A-47C2-B53C-D8E7EBF6EE23 @default.
- Q90642530 P2093 Q90642530-5E45F572-0879-4E95-A675-011570F92750 @default.
- Q90642530 P2093 Q90642530-6117E574-3D73-441E-9EB0-C5182B0B4BE0 @default.
- Q90642530 P2093 Q90642530-6642E803-036D-412B-BA95-BB228E97BB35 @default.
- Q90642530 P2093 Q90642530-68C5D7D0-873F-46D7-A1D3-785E94ADE00C @default.
- Q90642530 P2093 Q90642530-69F6E195-416D-4762-B3CA-5481CEEDFA5D @default.
- Q90642530 P2093 Q90642530-6C4FDD07-6445-43F8-AE8B-55B4244289F1 @default.
- Q90642530 P2093 Q90642530-8B343006-0593-4634-9AD1-1EB1D15D83AC @default.
- Q90642530 P2093 Q90642530-A4F64A6B-450F-46F7-BC68-98CF98892120 @default.
- Q90642530 P2093 Q90642530-AC887939-4E60-4522-B6CB-DA2C6BF1D19E @default.
- Q90642530 P2093 Q90642530-B6735552-9940-48EB-BBFD-F1AD0ABF7CA4 @default.
- Q90642530 P2093 Q90642530-BC653E3D-0FDC-4B02-96A9-E3CA987C5D9A @default.
- Q90642530 P2093 Q90642530-C982E38E-1509-4F49-8183-3764A985F6BD @default.
- Q90642530 P2093 Q90642530-CF4BC8BC-7DF9-453E-8F55-2F3412336795 @default.
- Q90642530 P2093 Q90642530-E41E56E5-15E3-4C0F-9929-E439A32E73F9 @default.
- Q90642530 P2093 Q90642530-E6E88034-D1CC-4D7E-BD7A-CB88E92A651E @default.
- Q90642530 P275 Q90642530-7bdc7cbc-c504-487b-9a86-6d450dc3b8db @default.
- Q90642530 P2860 Q90642530-00D54C3A-A563-4E79-BBE4-2D8CB9B296C6 @default.
- Q90642530 P2860 Q90642530-0825A91C-AD87-414A-BBAC-28CA67700F8E @default.
- Q90642530 P2860 Q90642530-0E9E807A-F29C-49BC-ACBC-F52D9AD92E34 @default.
- Q90642530 P2860 Q90642530-11BB1868-CEDB-4692-B786-8D956A16371D @default.
- Q90642530 P2860 Q90642530-143ACA9F-3D09-44EB-B09C-6A1FD5DBCC7C @default.
- Q90642530 P2860 Q90642530-15EDF32B-C2DE-4814-82A1-6982EA54DA64 @default.
- Q90642530 P2860 Q90642530-1765830A-A764-4C0F-8988-EB63D9981B15 @default.
- Q90642530 P2860 Q90642530-1C19A4CC-C653-4BA4-BCA0-0419C2910CD4 @default.
- Q90642530 P2860 Q90642530-244B561C-E886-49D4-8362-E76478141943 @default.